Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193492
Status:
COMPLETED
Last Update Posted:
2015-01-05
First Post:
2005-08-22
Brief Title:
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkins Lymphoma
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Study Overview
Official Title:
Rituximab - Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkins Lymphoma A Randomized Phase II Trial
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the feasibility efficacy and safety of adding bevacizumab to rituximab compared to rituximab alone in patients with previously treated follicular non-hodgkins lymphoma NHL whose disease has progressed following at least one previous chemotherapy regimen and not more than 2 previous chemotherapy regimens
Detailed Description:
Upon determination of eligibility patients will randomly be assigned to one of two treatment arms
Rituximab
Rituximab bevacizumab
For every 2 patients randomized 1 will receive treatment number 1 rituximab and 1 patient will receive treatment number 2 rituximab bevacizumab This is not a blinded study so both the patient and doctor will know which treatment has been assigned
Rituximab
Rituximab bevacizumab
For every 2 patients randomized 1 will receive treatment number 1 rituximab and 1 patient will receive treatment number 2 rituximab bevacizumab This is not a blinded study so both the patient and doctor will know which treatment has been assigned
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U3234s | OTHER | Genentech-Roche | None |